1. Rapamycin golden jubilee and still the miraculous drug: a potent immunosuppressant, antitumor, rejuvenative agent, and potential contributor in COVID-19 treatment
   Mohamed A. Mohamed et al, 2022, Bioresources and Bioprocessing CrossRef
2. Immunosuppressant Medications in Pregnancy
   Antonio F. Saad et al, 2024, Obstetrics & Gynecology CrossRef
3. Neoadjuvant Therapy with Everolimus for Subependymal Giant Cell Astrocytoma: A Case Report
   Hiroki KARITA et al, 2023, NMC Case Report Journal CrossRef
4. Phenotypic Screening of Prospective Analgesics Among FDA‐Approved Compounds using an iPSC‐Based Model of Acute and Chronic Inflammatory Nociception
   Bryan James Black et al, 2024, Advanced Science CrossRef
5. Therapy in the Course of Kidney Graft Rejection—Implications for the Cardiovascular System—A Systematic Review
   Jakub Mizera et al, 2023, Life CrossRef
6. Radioligand Therapy with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade
   Adam Daniel Durma et al, 2023, Pharmaceuticals CrossRef
7. Novel Use of Dasiglucagon, a Soluble Glucagon Analog, for the Treatment of Hyperinsulinemic Hypoglycemia Secondary to Suspected Insulinoma: A Case Report
   Dana Reynolds et al, 2024, Hormone Research in Paediatrics CrossRef
8. A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancers
   David Starks et al, 2023, Cancer Medicine CrossRef
9. Pulmonary Complications of Everolimus in Liver Transplant Patients: A 10-Year Experience
   Mark S Obri et al, 2024, Cureus CrossRef
10. An insight into the risk factors of brain tumors and their therapeutic interventions
    Sumbal Rasheed et al, 2021, Biomedicine & Pharmacotherapy CrossRef
11. Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines
    Amr Mohamed et al, 2022, Cancers CrossRef
12. Safety and Efficacy of an Innovative Everolimus-Coated Balloon in a Swine Coronary Artery Model
    Christos S. Katsouras et al, 2023, Life CrossRef
13. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
    Ioannis Parodis et al, 2024, Kidney International Reports CrossRef
14. mTOR Signaling and Potential Therapeutic Targeting in Meningioma
    Benjamin Pinker et al, 2022, International Journal of Molecular Sciences CrossRef
15. Optimization of chromatography method with mass-spectrometry detection for quantitative determination of everolimus in whool human blood of patients after heart transplantation
    E.I. Bezvulyak et al, 2023, Laboratornaya sluzhba CrossRef
16. Anti-ageing effects of FDA-approved medicines: a focused review
    Koranit Thanapairoje et al, 2023, Journal of Basic and Clinical Physiology and Pharmacology CrossRef